Literature DB >> 24688764

The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 promotes enzymatic activity of matrixmetalloproteinase-2 in vitro.

C Freise, M Ruehl, U Erben, R W Farndale, R Somasundaram, M M Heimesaat.   

Abstract

Diseases such as liver fibrosis and intestinal inflammation are characterized by accumulated components of the extracellular matrix (ECM). Given that fibrillar collagen structures were shown to serve as storage site for inactive proforms of matrixmetalloproteinases (MMPs), modulating this MMP-collagen interaction might offer a rational interventional (therapeutic) approach to enhance degradation of accumulated ECM. The synthetic triple helical collagen analogue (Gly-Pro-Hyp)10 - (GPO)10 - was shown to trigger release and enzymatic activation of collagen sequestered proMMP-2. In the presented study, we, for the first time, investigated how MMP-(GPO)10 interaction impacts cellular responses in vitro. We found that recombinant proMMP-2 induced proliferation of hepatic stellate cells (HSC), which was enhanced after addition of (GPO)10 reaching comparable levels following incubation with fully activated MMP-2. In addition, (GPO)10 induced HSC migration similar to the platelet-derived growth factor subunit-B. Further, the MMP-2-dependent invasion of HT1080 fibrosarcoma cells through an ECM membrane was enhanced after addition of (GPO)10. Since cellular proliferation and migration concomitant with matrix degradation is stimulated, we conclude that the MMP-(GPO)10 interaction also functions in a physiological environment. Thus, a potential therapeutic effect of (GPO)10 should be further tested in animal models for MMP-associated diseases such as colitis or fibrosis.

Entities:  

Keywords:  (GPO)10; HT1080; enzymatic activation; extracellular matrix; gelatinases; hepatic stellate cells; in vitro; matrixmetalloproteinase; proMMP-2

Year:  2012        PMID: 24688764      PMCID: PMC3962753          DOI: 10.1556/EuJMI.2.2012.3.3

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  25 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.

Authors:  Florencia E Castaneda; Baljit Walia; Matam Vijay-Kumar; Neal R Patel; Susanne Roser; Vasantha L Kolachala; Mauricio Rojas; Lixin Wang; Gabriela Oprea; Pallavi Garg; Andrew T Gewirtz; Jesse Roman; Didier Merlin; Shanthi V Sitaraman
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

3.  Type I collagen stabilization of matrix metalloproteinase-2.

Authors:  S M Ellerbroek; Y I Wu; M S Stack
Journal:  Arch Biochem Biophys       Date:  2001-06-01       Impact factor: 4.013

Review 4.  Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.

Authors:  Chrisostomi Gialeli; Achilleas D Theocharis; Nikos K Karamanos
Journal:  FEBS J       Date:  2010-11-19       Impact factor: 5.542

5.  Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17.

Authors:  Melba Muñoz; Markus M Heimesaat; Kerstin Danker; Daniela Struck; Uwe Lohmann; Rita Plickert; Stefan Bereswill; André Fischer; Ildikò Rita Dunay; Kerstin Wolk; Christoph Loddenkemper; Hans-Willi Krell; Claude Libert; Leif R Lund; Oliver Frey; Christoph Hölscher; Yoichiro Iwakura; Nico Ghilardi; Wenjun Ouyang; Thomas Kamradt; Robert Sabat; Oliver Liesenfeld
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

6.  The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity.

Authors:  Christian Freise; Ulrike Erben; Marion Muche; Richard Farndale; Martin Zeitz; Rajan Somasundaram; Martin Ruehl
Journal:  Matrix Biol       Date:  2009-08-19       Impact factor: 11.583

Review 7.  PDGF and signal transduction in hepatic stellate cells.

Authors:  Massimo Pinzani
Journal:  Front Biosci       Date:  2002-08-01

8.  An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes.

Authors:  Christian Freise; Ulrike Erben; Ulf Neuman; Kiyoung Kim; Martin Zeitz; Rajan Somasundaram; Martin Ruehl
Journal:  J Nutr Biochem       Date:  2010-01-25       Impact factor: 6.048

9.  Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.

Authors:  S Milani; H Herbst; D Schuppan; C Grappone; G Pellegrini; M Pinzani; A Casini; A Calabró; G Ciancio; F Stefanini
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

10.  Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42.

Authors:  Martin Ruehl; Marion Muche; Christian Freise; Ulrike Erben; Ulf Neumann; Detlef Schuppan; Yury Popov; Walburga Dieterich; Martin Zeitz; Richard W Farndale; Rajan Somasundaram
Journal:  Fibrogenesis Tissue Repair       Date:  2011-01-06
View more
  3 in total

1.  A Lindera obtusiloba Extract Blocks Calcium-/Phosphate-Induced Transdifferentiation and Calcification of Vascular Smooth Muscle Cells and Interferes with Matrix Metalloproteinase-2 and Metalloproteinase-9 and NF-κB.

Authors:  Christian Freise; Ki Young Kim; Uwe Querfeld
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-30       Impact factor: 2.629

2.  Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases.

Authors:  Christian Freise; Nadja Kretzschmar; Uwe Querfeld
Journal:  BMC Cardiovasc Disord       Date:  2016-09-30       Impact factor: 2.298

3.  Hydroxyproline-containing collagen peptide derived from the skin of the Alaska pollack inhibits HIV-1 infection.

Authors:  In Seung Jang; Sun Joo Park
Journal:  Mol Med Rep       Date:  2016-11-16       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.